Allogeneic human adipose derived mesenchymal stem

N/A

Report date: 2024/12/03 20:00:08

Base Information

Drug NameAllogeneic human adipose derived mesenchymal stem
Drug Alias Name异体人源脂肪间充质干细胞注射液DK-001
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPerianal fistulaFistulaAnus Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJiangsu Dekang Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Dekang Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPerianal fistulaFistulaAnus Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A